Suncorporation (TYO:6736) will receive 3,489,202 shares of Nasdaq-listed Cellebrite DI, its equity-method affiliate, after Cellebrite's share price reached $17.5 on Nov. 1, 2024, according to a Wednesday filing on the Tokyo Stock Exchange.
This brings Suncorporation's total shares under the compensation agreement to 10.5 million, with no impact on operating profit as the shares are issued at no cost.
The issuance follows Cellebrite's 2021 NASDAQ listing agreement, which allows for up to 15 million shares to be distributed based on price thresholds.
Price (JPY): $8360.00, Change: $-90, Percent Change: -1.07%
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。